Showing results (51-60 of 510) with videos related to
Sort By:
Pageof 51
Trends in Neurosciences|June 17, 2000
Energetics in the pathogenesis of neurodegenerative diseasesM F BealMetabolism: Clinical and Experimental|September 1, 1990
Somatostatin in neurodegenerative illnessesM F BealScience (New York, N.Y.)|July 19, 1985
Reduced numbers of somatostatin receptors in the cerebral cortex in Alzheimer's diseaseM F Beal, M F Mazurek, V T Tran, et al.Annals of Neurology|September 1, 1986
Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer's diseaseM F Beal, M F Mazurek, G K Chattha, et al.Journal of Neuropathology and Experimental Neurology|January 1, 1987
Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington's diseaseR J Ferrante, N W Kowall, M F Beal, et al.Brain : a Journal of Neurology|December 1, 1987
Amino acid neurotransmitter abnormalities in Huntington's disease and the quinolinic acid animal model of Huntington's diseaseD W Ellison, M F Beal, M F Mazurek, et al.Science (New York, N.Y.)|November 1, 1985
Selective sparing of a class of striatal neurons in Huntington's diseaseR J Ferrante, N W Kowall, M F Beal, et al.Life Sciences|June 23, 1986
Reduced concentrations of arginine vasopressin and MHPG in lumbar CSF of patients with Korsakoff's psychosisR G Mair, P J Langlais, M F Mazurek, et al.Neuroscience Letters|February 14, 1986
An examination of neuropeptide Y postmortem stability in an animal model simulating human autopsy conditionsM F Beal, M F Mazurek, L J Lorenz, et al.Neuroscience Letters|April 22, 1988
Characterization of galanin-like immunoreactivity in the rat brain: effects of neonatal glutamate treatmentS M Gabriel, U M MacGarvey, J I Koenig, et al.Pageof 51